CIK 0001810182
- Non-accelerated filer
- Smaller reporting company
ALX ONCOLOGY HOLDINGS INC
Sign in to watch- Ticker
- ALXO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 850642577
- Phone
- +1 650-466-7125
- Business address
- 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-20 | Sandler Alan B. Director | Grant or award · Stock option (right to buy) | +10,100 | 10,100 | ||
| 2025-04-11 | Sandler Alan B. Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2025-01-21 | Sandler Alan B. Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2024-11-18 | Sandler Alan B. Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +600,000 | 600,000 | ||
| 2024-08-05 | Sandler Alan B. Director | Grant or award · Stock Option (right to buy) | +40,400 | 40,400 |
Page 1 of 1 · 5 trades